1. A method comprising:
communicating a file from a client to a server, the file containing information;
generating an applet based on the information;
communicating the applet from the server to the client;
executing the applet on the client to thereby cause searching for an additional file; and
communicating the additional file to the server, wherein the file comprises an INF file.
2. The method of claim 1 wherein the INF file comprises a printer INF file.
3. The method of claim 1 wherein the server comprises a printer server.
4. The method of claim 1 wherein the applet comprises a security signature.
5. The method of claim 1 wherein the information comprises file names.
6. The method of claim 1 wherein the information comprises a file name associated with the additional file.
7. The method of claim 1 wherein the executing includes searching a CD in a CD-ROM drive.
8. The method of claim 1 wherein the executing includes searching a memory associated with a camera.
9. The method of claim 1 wherein the executing includes searching for an image file.
10. The method of claim 1 wherein the executing includes invoking a request for a user’s input.
11. A computer-readable medium containing a computer program that is storable in memory and executable by a processor to configure a server to generate the applet of the method of claim 1.
12. A method for configuring a server comprising:
communicating a file from a client to the server, the file containing information;
generating an applet based on the information;
communicating the applet from the server to the client;
executing the applet on the client to thereby cause searching for an additional file, wherein executing includes searching a CD in a CD-ROM drive;
communicating the additional file to the server; and
configuring the server using at least the additional file.
13. The method of claim 12 wherein the file comprises an INF file.
14. The method of claim 13 wherein the INF file comprises a printer INF file.
15. The method of claim 12 wherein the server comprises a printer server.
16. The method of claim 12 wherein the applet comprises a security signature.
17. The method of claim 12 wherein the information comprises file names.
18. The method of claim 12 wherein the information comprises a file name associated with the additional file.
19. The method of claim 12 wherein the executing includes searching a CD in a CD-ROM drive.
20. A method for configuring an Internet Web server comprising:
communicating a file from a printer to the Web server, the file containing information;
generating an applet based on the information;
communicating the applet from the Web server to the printer;
executing the applet on the printer to thereby cause searching by the printer for an additional file;
communicating the additional file to the Web server; and
configuring the Web server using at least the additional file.
21. The method of claim 20 wherein the additional file comprises an image file.
22. The method of claim 20 wherein the configuring comprises associating the additional file with a Web page.
23. The method of claim 20 wherein the additional file comprises an image file associated with a Web page hosted by the Web server.
24. A method comprising:
communicating a file from a printer to a server, the file containing information;
generating an applet based on the information;
communicating the applet from the server to the printer;
executing the applet on the printer to thereby cause searching by the printer for an additional file;
communicating the additional file to the server; and
configuring the server using at least the additional file.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A platinum compound obtainable by the process comprising treating an aqueous solution comprising cisplatin with lipoic acid to provide a polynuclear platinum compound.
2. The compound of claim 1 wherein the aqueous solution is a saline solution.
3. The compound of claim 1 wherein lipoic acid is added in an alcohol solution.
4. The compound of claim 1 wherein treating an aqueous solution comprising cisplatin with lipoic acid comprises heating at about 60\xb0 C.
5. The compound of claim 1 wherein the polynuclear platinum compound has an average molecular weight greater than about 100 kD as determined by size exclusion chromatography.
6. A platinum compound obtainable by the process comprising:
treating an aqueous solution comprising cisplatin with silver nitrate to provide a reaction mixture; and
adding lipoic acid to the reaction mixture provide a polynuclear platinum compound.
7. The compound of claim 6 wherein lipoic acid is added in an alcohol solution.
8. The compound of claim 7 wherein adding lipoic acid to the reaction mixture provides a polynuclear platinum compound comprises heating at about 50\xb0 C.
9. The compound of claim 7 wherein the polynuclear platinum compound has an average molecular weight greater than about 100 kD as determined by size exclusion chromatography.
10. The compound of claim 6 wherein lipoic acid is added in a basic aqueous solution.
11. The compound of claim 10 wherein the polynuclear platinum compound has an average molecular weight of about 7 kD as determined by size exclusion chromatography.
12. A composition, comprising an amount of a compound of claim 1 effective to treat a proliferative disease in a human or animal subject when administered thereto, together with a pharmaceutically acceptable carrier.
13. The composition of claim 12, further comprising at least one additional agent for the treatment of cancer.
14. The composition of claim 13 wherein the at least one additional agent for the treatment of cancer is selected from flutamide, luprolide, tomoxifen, daunorubicin, fluorouracil, floxuridine, interferon alpha, methotrexate, plicamycin, mecaptopurine, thioguanine, adriamycin, carmustine, lomustine, cytarabine, cyclophosphamide, doxorubicin, estramustine, altretamine, hydroxyurea, ifosfamide, procarbazine, mutamycin, busulfan, mitoxantrone, streptozocin, bleomycin, dactinomycin, idamycin, medroxyprogesterone, estramustine, ethinyl estradiol, estradiol, leuprolide, megestrol, octreotide, diethylstilbestrol, chlorotrianisene, etoposide, podophyllotoxin, goserelin, melphalan, chlorambucil, methlorethamine, thiotepa, betamethasone, dicarbazine, asparaginase, leucovorin, mitotane, vincristine, vinblastine, and taxanes.
15. A method for treating a cancer disorder in a human or animal subject, comprising administering to the human or animal subject a composition comprising an amount of a compound of claim 1 effective to treat the human or animal subject.
16. The method of claim 15 wherein the composition further comprises at least one additional agent for the treatment of cancer.
17. The method of claim 16 wherein the at least one additional agent for the treatment of cancer is selected from flutamide, luprolide, tomoxifen, daunorubicin, fluorouracil, floxuridine, interferon alpha, methotrexate, plicamycin, mecaptopurine, thioguanine, adriamycin, carmustine, lomustine, cytarabine, cyclophosphamide, doxorubicin, estramustine, altretamine, hydroxyurea, ifosfamide, procarbazine, mutamycin, busulfan, mitoxantrone, streptozocin, bleomycin, dactinomycin, idamycin, medroxyprogesterone, estramustine, ethinyl estradiol, estradiol, leuprolide, megestrol, octreotide, diethylstilbestrol, chlorotrianisene, etoposide, podophyllotoxin, goserelin, melphalan, chlorambucil, methlorethamine, thiotepa, betamethasone, dicarbazine, asparaginase, leucovorin, mitotane, vincristine, vinblastine, and taxanes.
18. The method of claim 15 wherein the cancer disorder is at least one of primary melanoma, metastatic melanoma, thymoma, lymphoma, sarcoma, NSC lung cancer, SC lung cancer, gastric cancer, liver cancer, non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, leukemia, testicular cancer, uterine cancer, cervical cancer, bladder cancer, kidney cancer, colon cancer, colorectal cancer, breast cancer, prostate cancer, ovarian cancer, or pancreatic cancer.